Rho GTPase signaling at the synapse: Implications for intellectual disability

Experimental Cell Research

Volumn 319, Issue 15, 2013, Pages 2368-2374

  Ba, Wei ^a   van der Raadt, Jori ^a   Nadif Kasri, Nael ^a,b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intellectual disability; Rho GTPase; Synapse; Synaptic plasticity

Indexed keywords

AMPA RECEPTOR; ARHGEF6 PROTEIN; BRAIN PROTEIN; COLLYBISTIN; MENTAL DISORDER ASSOCIATED GAP PROTEIN; OLIGOPHRENIN 1; P21 ACTIVATED KINASE 3; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; CELL FUNCTION; CELL STRUCTURE; DENDRITIC SPINE; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; INTELLECTUAL IMPAIRMENT; INTRACELLULAR SIGNALING; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION;

EID: 84883221005     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.05.033     Document Type: Review

References (73)

1. Van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 2011, 45:81-104.
2. Chelly J., Khelfaoui M., Francis F., Chérif B., Bienvenu T. Genetics and pathophysiology of mental retardation. Eur. J. Hum. Genet.: EJHG 2006, 14:701-713.
3. Humeau Y., Gambino F., Chelly J., Vitale N. X-linked mental retardation: focus on synaptic function and plasticity. J. Neurochem. 2009, 109:1-14.
4. Pavlowsky A, Chelly J., Billuart P. Major synaptic signaling pathways involved in intellectual disability. Mol. Psychiatry. 2012, 17:663.
5. Nadif Kasri N., Van Aelst L. Rho-linked genes and neurological disorders. Pflügers Archiv: Eur. J. Physiol. 2008, 455:787-797.
6. Valnegri P., Sala C., Passafaro M. Synaptic dysfunction and intellectual disability. Adv. Exp. Med. Biol. 2012, 433-449.
7. Aspenström P., Fransson A., Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 2004, 377:327-337.
8. Govek E.-E., Hatten M.E., Van Aelst L. The role of Rho GTPase proteins in CNS neuronal migration. Dev. Neurobiol. 2011, 71:528-553.
9. Newey S.E., Velamoor V., Govek E.-E., Van Aelst L. Rho GTPases, dendritic structure, and mental retardation. J. Neurobiol. 2005, 64:58-74.
10. Cingolani L.a, Goda Y. Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat. Rev. Neurosci. 2008, 9:344-356.
11. Honkura N., Matsuzaki M., Noguchi J., Ellis-Davies G.C.R., Kasai H. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron 2008, 57:719-729.
12. Kessels H.W., Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 2009, 61:340-350.
13. Okamoto K.-I., Nagai T., Miyawaki A., Hayashi Y. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat. Neurosci. 2004, 7:1104-1112.
14. Zhou Q., Homma K.J., Poo M. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 2004, 44:749-757.
15. Rex C.S. Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J. Cell. Biol. 2009, 186:85-97.
16. Murakoshi H., Wang H., Yasuda R. Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature 2011, 472:100-104.
17. Okada H., Soderling S.H. Signaling through actin to regulate spine formation and function. Open Neurosci. J. 2009, 3:97-107.
18. Govek E.-E. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 2004, 7:364-372.
19. Nakano-Kobayashi A., Nadif Kasri N., Newey S.E., Van Aelst L. The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1. Curr. Biol.: CB 2009, 19:1133-1139.
20. Khelfaoui M. Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation. Hum. Mol. Genet. 2009, 18:2575-2583.
21. Bergmann C. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. Brain: a J.Neurol. 2003, 126:1537-1544.
22. Philip N. Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia. J. Med. Genet. 2003, 441-446.
23. Des Portes V. Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin-1 gene. Am. J. Med. Genet. A. 2004, 124A:364-371.
24. Zanni G. Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia. Neurology 2005, 1364-1369.
25. Nadif Kasri N., Nakano-Kobayashi A., Malinow R., Li B., Van Aelst L. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 2009, 23:1289-1302.
26. Nadif Kasri N., Nakano-Kobayashi A., Van Aelst L. Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Neuron 2011, 72:300-315.
27. Ahmadian G. Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. EMBO J. 2004, 23:1040-1050.
28. Khelfaoui M. Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:9439-9450.
29. Powell A.D. Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation. J. Physiol. 2012, 590:763-776.
30. Valnegri P. A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbα. Nat. Neurosci. 2011, 14:1293-1301.
31. Didde R., Sigafoos J. A review of the nature and treatment of sleep disorders in individuals with developmental disabilities. Res. Dev. Disabil. 2001, 22:255-272.
32. Kutsche K. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat. Genet. 2000, 26:247-250.
33. Feng Q., Baird D., Cerione R. a Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix. EMBO J. 2004, 23:3492-3504.
34. Nodé-Langlois R., Muller D., Boda B. Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis. J. Cell. Sci. 2006, 119:4986-4993.
35. Ramakers G.J. a et al. Dysregulation of Rho GTPases in the αPix/Arhgef6 mouse model of X-linked intellectual disability is paralleled by impaired structural and synaptic plasticity and cognitive deficits. Hum. Mol. Genet. 2012, 21:268-286.
36. Allen K.M. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 1998, 20:25-30.
37. Bienvenu T. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am. J. Med. Genet. 2000, 93:294-298.
38. Gedeon A.K., Nelson J., Gécz J., Mulley J.C. X-linked mild non-syndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3. Am. J. Med. Genet. A. 2003, 120A:509-517.
39. Rousseau V., Goupille O., Morin N., Barnier J.-V. A new constitutively active brain PAK3 isoform displays modified specificities toward Rac and Cdc42 GTPases. J. Biol. Chem. 2003, 278:3912-3920.
40. Edwards D.C., Sanders L.C., Bokoch G.M., Gill G.N. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell. Biol. 1999, 1:253-259.
41. Y. Meng, et al., Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice neuron 35 (2002) 121-133.
42. Boda B. The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J. Neurosci.: 2004, 24:10816-10825.
43. Hayashi M.L. Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice. Neuron 2004, 42:773-787.
44. Meng J., Meng Y., Hanna A., Janus C., Jia Z. Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J. Neurosci.: Off. J. Soc. Neurosc. 2005, 25:6641-6650.
45. Dubos A. Alteration of synaptic network dynamics by the intellectual disability protein PAK3. J. Neurosci.: Off. J. Soc. Neurosc. 2012, 32:519-527.
46. Hayashi M.L. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11489-11494.
47. Dolan B.M. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5671-5676.
48. Ma Q.-L., Yang F., Frautschy S.a, Cole G.M. PAK in Alzheimer disease, Huntington disease and X-linked mental retardation. Cell. Logistics 2012, 2:117-125.
49. Hoogenraad C.C., Akhmanova A., Galjart N., De Zeeuw C.I. LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome. Bioessays: News Rev. Mol. Cell. Dev. Biol. 2004, 26:141-150.
50. Endris V. The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11754-11759.
51. Hamdan F.F. Srgap3/megap. Arch. Neurol. 2009, 675-677.
52. Soderling S.H. The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nat. Cell. Biol. 2002, 4:970-975.
53. Wong K. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001, 107:209-221.
54. Carlson B.R. WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs long-term memory. J. Neurosci.: 2011, 31:2447-2460.
55. Soderling S.H. A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J. Neurosci.: 2007, 27:355-365.
56. Harvey K. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J. Neurosci.: 2004, 24:5816-5826.
57. Marco E.J. ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal. J. Med. Genet. 2008, 45:100-105.
58. Kalscheuer V.M. A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum. Mutat. 2009, 30:61-68.
59. Lesca G. De novo Xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features. Am. J. Med. Genet. Part A 2011, 155A:1706-1711.
60. Shimojima K. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. J. Hum. Genet. 2011, 56:561-565.
61. Tyagarajan S.K., Ghosh H., Harvey K., Fritschy J.-M. Collybistin splice variants differentially interact with gephyrin and Cdc42 to regulate gephyrin clustering at GABAergic synapses. J. Cell. Sci. 2011, 124:2786-2796.
62. Kneussel M., Engelkamp D., Betz H. Distribution of transcripts for the brain-specific GDP/GTP exchange factor collybistin in the developing mouse brain. Eur. J. Neurosci. 2001, 13:487-492.
63. Kins S., Betz H., Kirsch J. Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin. Nat. Neurosci. 2000, 3:22-29.
64. Reid T. Bathoorn, a, Ahmadian, M. R. & Collard, J. G. Identification and characterization of hPEM-2, a guanine nucleotide exchange factor specific for Cdc42. J. Biol. Chem. 1999, 274:33587-33593.
65. Chiou T.-T. Differential regulation of the postsynaptic clustering of γ-aminobutyric acid type A (GABAA) receptors by collybistin isoforms. J. Biol. Chem. 2011, 286:22456-22468.
66. Patrizi A. Selective localization of collybistin at a subset of inhibitory synapses in brain circuits. J. Comp. Neurol. 2012, 520:130-141.
67. Reddy-Alla S. PH-domain-driven targeting of collybistin but not Cdc42 activation is required for synaptic gephyrin clustering. Eur. J. Neurosci. 2010, 31:1173-1184.
68. Körber C. Effects of distinct collybistin isoforms on the formation of GABAergic synapses in hippocampal neurons. Mol. Cell. Neurosci. 2012, 50:250-259.
69. Poulopoulos A. Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 2009, 63:628-642.
70. Saiepour L. Complex role of collybistin and gephyrin in GABAA receptor clustering. J. Biol. Chem. 2010, 285:29623-29631.
71. Papadopoulos T. Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J. 2007, 26:3888-3899.
72. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain. Res. Rev. 2002, 39:29-54.
73. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb. Cort. (New York, N.Y.: 1991) 2000, 10:981-991.